Testing effectiveness (Phase 2)Ended earlyNCT02658812
What this trial is testing
Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery
Who this might be right for
Malignant Chest Wall NeoplasmRecurrent Breast CarcinomaRecurrent Inflammatory Breast Carcinoma+2 more
M.D. Anderson Cancer Center 11